- Home
- JBGS vs CERT Comparison
JBGS vs CERT Comparison
Compare JBGS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBGS | CERT |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.3M | 860.9M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JBGS | CERT |
|---|---|---|
| Price | $14.79 | $5.90 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $15.00 | $11.67 |
| AVG Volume (30 Days) | 563.7K | ★ 3.5M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $498,598,000.00 | $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $13.99 | $4.45 |
| 52 Week High | $24.30 | $13.88 |
Technical Indicators
Market Signals| Indicator | JBGS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 58.09 |
| Support Level | $14.13 | $5.19 |
| Resistance Level | $16.07 | $6.47 |
| Average True Range (ATR) | 0.38 | 0.36 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 46.75 | 88.68 |
Price Performance
Historical ComparisonAbout JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.